Wade Smith

Wade Smith Email and Phone Number

Chief Financial Officer & Chief Business Officer - Biotech and Pharmaceuticals @ Elevar Therapeutics
Wade Smith's Location
Greater Pittsburgh Region, United States, United States
Wade Smith's Contact Details

Wade Smith personal email

n/a
About Wade Smith

Creative, entrepreneurial, high-energy, technically savvy pharmaceutical executive with demonstrated proficiency in raising capital, commercial strategy, product launch, customer negotiations, business development, building successful commercial and finance teams, leading international expansions, investor relations, business process improvement, and variance analysis. At Elevar Therapeutics my responsibilities include capital acquisition & deployment, accounting/controlling, financial planning & analysis, business development & portfolio optimization, marketing, market access, commercial operations, and pricing functions in addition to serving as the corporate secretary. Having started my career in public accounting, I still hold an active CPA license in the Commonwealth of Pennsylvania.

Wade Smith's Current Company Details
Elevar Therapeutics

Elevar Therapeutics

View
Chief Financial Officer & Chief Business Officer - Biotech and Pharmaceuticals
Wade Smith Work Experience Details
  • Elevar Therapeutics
    Chief Financial Officer & Chief Business Officer
    Elevar Therapeutics Jul 2024 - Present
    Fort Lee, New Jersey, Us
    In addition to leading the capital markets, finance, and accounting functions at Elevar Therapeutics I now have the opportunity to lead the commercial functions and business development. My responsibility includes building the commercial organization including leading marketing in developing product positioning and messaging, building efficient sales operations data flow for market opportunity assessment and sales force sizing/targeting, market access including patient services, and designing trade and distribution channel strategy in preparation for the launch our first products. My remit also contains business development including out licensing our products to commercial partners and leading our portfolio opportunity review board in our evaluation of new molecules. What I am enjoying most though is collaborating with the other executive leadership team members to build the corporate strategy that will position Elevar for success in the future.
  • Elevar Therapeutics
    Chief Financial Officer
    Elevar Therapeutics Aug 2022 - Present
    Fort Lee, New Jersey, Us
    Leading the finance and accounting function at Elevar Therapeutics as we build the organization that will continue to develop meaningful therapies to address unmet medical needs, building the commercial organization in preparation for the launch our first products, engaging with investors to maintain a strong financial position, and partnering with the board, CEO, and executive leadership team to set the long-term strategy of the organization. Implemented internal controls over financial reporting and conducted an IPO readiness assessment. Spearheaded the creation of a long-range plan and discounted cash flow model for 409a valuations. Prepared and presented non-deal road show (NDR) and financing transaction related presentations to investors, lenders, and bankers. Built out an investor relations function including a virtual data room for use in financing and business development / business partnering transactions. Holding the position of Corporate Secretary since May 2022 I have lead the corporate governance function and participated in or chaired board meetings and annual shareholders meetings.
  • Elevar Therapeutics
    Vice President Finance
    Elevar Therapeutics Jan 2022 - Jul 2022
    Fort Lee, New Jersey, Us
    Leading Elevar’s financial and accounting operations and guiding strategic financial evolution. Selected and implemented new ERP (Netsuite). Implemented Legal contracts Management System (Linksquares).Implemented budgeting, forecasting and built out FP&A function.
  • Viatris
    Head Of Commercial Finance Mylan Institutional
    Viatris Oct 2017 - Jan 2022
    Pittsburgh, Pennsylvania, Us
    Functioning as the chief financial officer / chief business officer for this $1 billion + division of a global health care company with dual reporting to the division president & group finance head, I have the opportunity to do work that I love, serving customers that I value and appreciate. As a member of the executive leadership team of this division I have the opportunity to set and implement customer, product, and contracting strategy, bring valuable new products and services to market, and achieve financial targets through ownership of the P&L. In 2018 Mylan launched it's first Biosimilar Fulphila (pegfilgrastim) in the US market and in 2019 we launched Ogivri (trastuzumab). I was a part of a small cross-functional executive team that built a new sales force and marketing function and crafted the go-to-market strategy including launch pricing, customer contracting, managed market access strategy, and sales targeting which helped make these launches successful.
  • Viatris
    Director Mylan Institutional Commercial Finance
    Viatris Dec 2014 - Dec 2017
    Pittsburgh, Pennsylvania, Us
    This is the most commercially focused role I have had the opportunity to take on, challenging me to learn the intricacies of the Institutional pharmaceutical market, our customers, and our products. Partnering with Mylan Institutional commercial leadership, business development, sales, marketing, pricing, supply chain, and operations teams to participate in implementing strategy including financial insights for the decision making process as well as bringing ideas to the table. I lead a team of skilled financial analysts/managers who, using innovative processes and data visualization tools, provide analysis and insights that enable revenue increasing and cost saving decisions to be made with confidence in addition to meeting the forecasting, planning, reporting needs of the business.
  • Viatris
    Director North America Commercial Finance (Mylan)
    Viatris Mar 2014 - Dec 2014
    Pittsburgh, Pennsylvania, Us
    In this role I reported to the North American CFO and functioned as Finance Project Manager. I had the opportunity to make a measurable impact on profitability by supporting the CFO and business unit controllers in major initiatives affecting customers, suppliers, and business process improvement including major product launches, supplier settlement negotiations, and customer claim settlement negotiations.
  • Viatris
    Senior Manager - General Accounting (Mylan)
    Viatris Dec 2012 - Mar 2014
    Pittsburgh, Pennsylvania, Us
    Joined Mylan in late 2012 as Senior Manager - General Accounting tasked with implementing the vision of creating a regional financial shared service center including deploying new tools, business processes, and expanding use of the center. In late 2013, accepted an assignment to manage a critical finance transformation project and carried the informal title NA Finance PMO.
  • Taggart Global, Llc
    Director Of Global Accounting & Financial Reporting
    Taggart Global, Llc Sep 2006 - Oct 2012
    Finance lead on domestic and international Business Development (M&A) including 5 completed acquisitions, 6 new subsidiary startups. Significant travel to Canada, China, South Africa, and Trinidad. Finance lead including development and delivery of road show presentation when the company attempted to sell itself. Created foreign exchange risk management (FX hedging) program to limit currency risk and served as FX trader. Implemented ERP system that improved quality of and access to business critical data. Developed internal and external reporting processes and procedures to effectively explain business results and project variances. Maintained total headcount in finance while top line revenue doubled. Selected and implemented international tax planning strategies that minimized income and withholding tax rates using Luxembourg and St. Lucia holding companies.
  • Nova Chemicals
    Team Leader Corporate Financial Planning & Reporting
    Nova Chemicals Aug 2000 - Sep 2006
    Calgary, Alberta, Ca
    Hired in 2000 as Senior Analyst for a $3B division. Promoted to External Reporting Manager and served as finance lead on US S-1 filing (IPO), wrote MD&A, and prepared Annual & Quarterly financial reports. Served as accounting lead on commodity, interest rate, and Fx hedging program. Promoted to Team Leader - Corporate Planning & Reporting, leading the financial consolidation for actual, budget, and forecast in SAP and Hyperion, balance sheet analysis, and statement note preparation.
  • Guthrie Belczyk & Associates, Pc
    Audit Manager
    Guthrie Belczyk & Associates, Pc Nov 1998 - Aug 2000
    Served as Audit manager on the firms largest engagements from preparing the audit plan, managing field work, and report preperation. Income tax return preperation for closly held corporations, partnerships, and wealthy individuals. Grew the companies book of business through effective networking and personal relationships.
  • Smith Machine
    Controller
    Smith Machine 1997 - 1998
    Chapter 11 steel processor, turnaround opportunity. Restructured debt, leveraged working capital to improve cash flow, improved margins by effectively measuring productivity and reducing operating cost.
  • Ucp Of Southwestern Pennsylvania
    Cfo/Controller
    Ucp Of Southwestern Pennsylvania 1996 - 1997
    Small ($6M) not-for-profit health & human services agency. Significant forensic exercise to clean up accounting irregularities left by previous CFO. Implemented new accounting software. Worked to secure additional government grants that doubled the size of the organization.
  • Taggart Mitchell & Associates Pc
    Audit Senior
    Taggart Mitchell & Associates Pc 1993 - 1996
    Great small firm that gave me an opportunity to learn public accounting and get my CPA.

Wade Smith Skills

Financial Reporting Finance Accounting Leadership Auditing Corporate Finance Financial Analysis Forecasting Business Strategy Financial Accounting Variance Analysis Cash Flow Business Process Improvement Strategic Planning Certified Public Accountant Cpa Budgeting Sap Products Management Investor Relations Financial Forecasting

Wade Smith Education Details

  • Pennwest California
    Pennwest California
    Accounting And Business/Management

Frequently Asked Questions about Wade Smith

What company does Wade Smith work for?

Wade Smith works for Elevar Therapeutics

What is Wade Smith's role at the current company?

Wade Smith's current role is Chief Financial Officer & Chief Business Officer - Biotech and Pharmaceuticals.

What is Wade Smith's email address?

Wade Smith's email address is wa****@****lan.com

What schools did Wade Smith attend?

Wade Smith attended Pennwest California.

What are some of Wade Smith's interests?

Wade Smith has interest in Travel Are Great Family Fun, Coaching, Running, Catching, My Daughter Is A Pitcher, General Fitness, Softball.

What skills is Wade Smith known for?

Wade Smith has skills like Financial Reporting, Finance, Accounting, Leadership, Auditing, Corporate Finance, Financial Analysis, Forecasting, Business Strategy, Financial Accounting, Variance Analysis, Cash Flow.

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant

Download 750 million emails and 100 million phone numbers

Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.